Legal Support for Public-Private Partnership Projects in Life Sciences and Healthcare

Legal support for public-private partnership projects in healthcare and pharmaceuticals by BRACE Law Firm

Comprehensive Legal Counsel for PPP Projects in Life Sciences and Healthcare

Providing sophisticated legal support for public-private partnership (PPP) projects in healthcare and pharmaceuticals represents a cornerstone of BRACE Law Firm's practice.

Life Sciences & Healthcare constitute primary areas of sector specialization for the attorneys at BRACE Law Firm. Within this framework, we deliver premium legal counsel to domestic and international manufacturers and distributors of medicinal products, medical devices, and dietary supplements under both national and international legal regimes.

Structuring and Transactional Execution of PPP Projects

The primary statutory framework governing public-private partnerships in the Russian Federation is Federal Law No. 224-FZ "On Public-Private Partnerships, Municipal-Private Partnerships in the Russian Federation, and Amending Certain Statutory Acts of the Russian Federation." Pursuant to this statute, a public-private or municipal-private partnership is a legally binding, time-limited cooperation based on the pooling of resources and distribution of risks between a public partner and a private partner. This collaboration is executed via a formal PPP or MPP agreement designed to attract private investment into the economy, guarantee the accessibility of goods, works, and services by state and municipal bodies, and enhance their baseline quality. Under this framework, only a domestic legal entity may act as a private partner.

Under active state targeted initiatives, public-private partnerships are intended to facilitate the development of critical infrastructure, optimize scientific, technological, manufacturing, and human resource capabilities, and enhance the digital information infrastructure of the pharmaceutical and medical equipment industries.

Legal Management of Concession Agreements and PPP Transactions

A concession agreement structurally serves as an alternative mechanism designed to channel private venture capital into state-regulated sectors of the economy, operating similarly to standard PPP frameworks.

Pursuant to a concession agreement, the concessionaire undertakes to construct and/or rehabilitate designated real or personal property at its own expense—the title to which resides or will reside with the grantor—and to operate such assets for a contractually specified duration. While the scope of a concession agreement is narrower compared to standard PPP frameworks, a foreign legal entity may act as a concessionaire. Furthermore, another structural distinction is that a private partner may acquire ownership rights to a PPP project asset, whereas under a concession agreement, the underlying asset remains proprietary to the public grantor.

Whether executing a PPP agreement or a concession framework, a meticulous risk-allocation analysis of contractual terms is critical, alongside active legal advocacy during negotiations to resolve commercial disagreements between partners.

Regulatory Analysis and Strategic Project Risk Assessment

Executing public-private partnerships within the life sciences and healthcare sectors entails unique regulatory parameters. Integrating private sector enterprises must not only achieve successful project implementation but also ensure long-term commercial viability and return on investment. Concurrently, the market circulation of medicinal products and healthcare operations face stringent oversight. For instance, structuring a pharmaceutical PPP requires navigating specific compliance baselines regarding drug manufacturing, clinical trial validations, marketing authorizations, and state price controls.

To achieve these objectives, formulating a comprehensive master concept for the PPP is vital, alongside executing an in-depth market feasibility study to validate the underlying financial and legal models.

Beyond engineering a robust commercial project layout, maintaining continuous compliance monitoring throughout its execution lifecycle is imperative. This necessity arises because public-private partnerships transcend standard bilateral covenants, requiring active and ongoing liaison with third-party organizations and administrative regulatory bodies.

Scope of Legal Services for PPP Projects and Concessions

  1. Advising on regulatory and transactional frameworks governing PPP agreements and concession covenants in life sciences;
  2. Assisting with the formulation and conceptual engineering of public-private partnership models;
  3. Delivering end-to-end legal support throughout the execution phase of healthcare PPPs and concessions;
  4. Managing commercial negotiations and representing client interests in dealings between public and private stakeholders;
  5. Drafting and conducting rigorous legal audits of concession agreements, joint venture contracts, and ancillary project documentation;
  6. Formulating custom compliance instruments, petitions, and corporate applications critical to the project lifecycles;
  7. Providing adjacent legal counsel and cross-border regulatory advocacy tailored to healthcare infrastructure ventures.
E-mail
info@brace-lf.com

Send us a request with a detailed description of the issue.

Our phone
+7 (495) 147-11-03

Contact us by phone.

Clients & Partners

65.png
68.png
69.png
73.png
75.png
fitera.jpg
imko.png
logo.png
Logo_RED_RGB_Rus.png
logo_SK_2.png